New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
American Urological Association: Genomic urine test accurately predicts bladder cancer

American Urological Association: Genomic urine test accurately predicts bladder cancer

by Lori SolomonA new genomic urine test can predict bladder cancer as many as 12 years before clinical signs and symptoms emerge, according to a study presented at the annual meeting of the American U
World medicine December 12,2023
American Urological Association: Genomic urine test accurately predicts bladder cancer

American Urological Association: Genomic urine test accurately predicts bladder cancer

by Lori SolomonA new genomic urine test can predict bladder cancer as many as 12 years before clinical signs and symptoms emerge, according to a study presented at the annual meeting of the American U
World medicine December 12,2023
Every cancer is unique: Why different cancers require different treatments, and how evolution drives drug resistance

Every cancer is unique: Why different cancers require different treatments, and how evolution drives drug resistance

by Joshua Warrick, David DeGraff and Monika Joshi,The ConversationMost tumors are made up of many different kinds of cancer cells, as shown in this pancreatic cancer sample from a mouse. Credit:
World medicine December 12,2023
Every cancer is unique: Why different cancers require different treatments, and how evolution drives drug resistance

Every cancer is unique: Why different cancers require different treatments, and how evolution drives drug resistance

by Joshua Warrick, David DeGraff and Monika Joshi,The ConversationMost tumors are made up of many different kinds of cancer cells, as shown in this pancreatic cancer sample from a mouse. Credit:
World medicine December 12,2023
A step toward treating chemotherapy-resistant prostate cancer

A step toward treating chemotherapy-resistant prostate cancer

byAmerican Chemical SocietyCredit:ACS Central Science(2023). DOI: 10.1021/acscentsci.3c00286Prostate cancer is a leading cause of death among American men, and it's resistant to
World medicine December 12,2023
A step toward treating chemotherapy-resistant prostate cancer

A step toward treating chemotherapy-resistant prostate cancer

byAmerican Chemical SocietyCredit:ACS Central Science(2023). DOI: 10.1021/acscentsci.3c00286Prostate cancer is a leading cause of death among American men, and it's resistant to
World medicine December 12,2023
Ovarian cancer drug to enter phase II clinical trial

Ovarian cancer drug to enter phase II clinical trial

byInstitute of Cancer ResearchOur Center for Cancer Drug Discovery building—now the home of our drug discovery scientists. Credit: Institute of Cancer ResearchAn innovative cancer drug discovere
World medicine December 12,2023
Ovarian cancer drug to enter phase II clinical trial

Ovarian cancer drug to enter phase II clinical trial

byInstitute of Cancer ResearchOur Center for Cancer Drug Discovery building—now the home of our drug discovery scientists. Credit: Institute of Cancer ResearchAn innovative cancer drug discovere
World medicine December 12,2023
Ovarian cancer study identifies key genes for potential treatments

Ovarian cancer study identifies key genes for potential treatments

byImperial College LondonCredit: CC0 Public DomainNew research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment t
World medicine December 12,2023
Ovarian cancer study identifies key genes for potential treatments

Ovarian cancer study identifies key genes for potential treatments

byImperial College LondonCredit: CC0 Public DomainNew research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment t
World medicine December 12,2023
New surgical method for ovarian cancer lights up lesions

New surgical method for ovarian cancer lights up lesions

by Joel Streed,Mayo ClinicCredit: Mayo ClinicMayo Clinic scientists are shining light on ovarian cancer. Astudypublished in 2022 in theJournal of Clinical Oncologyexplore
World medicine December 12,2023
New surgical method for ovarian cancer lights up lesions

New surgical method for ovarian cancer lights up lesions

by Joel Streed,Mayo ClinicCredit: Mayo ClinicMayo Clinic scientists are shining light on ovarian cancer. Astudypublished in 2022 in theJournal of Clinical Oncologyexplore
World medicine December 12,2023
Ovarian cancer's protective barrier: How the tumor matrix teaches cells to disarm immune attack

Ovarian cancer's protective barrier: How the tumor matrix teaches cells to disarm immune attack

byQueen Mary, University of LondonHD MAMs have a reduced phagocytic response and alter T cell activation in the presence of CD3 and CD28 stimulation. MAMs were cultured for 14 days and K562 cell
World medicine December 12,2023
Ovarian cancer's protective barrier: How the tumor matrix teaches cells to disarm immune attack

Ovarian cancer's protective barrier: How the tumor matrix teaches cells to disarm immune attack

byQueen Mary, University of LondonHD MAMs have a reduced phagocytic response and alter T cell activation in the presence of CD3 and CD28 stimulation. MAMs were cultured for 14 days and K562 cell
World medicine December 12,2023
Appropriate use criteria for lymphoscintigraphy in sentinel node mapping and lymphedema/lipedema

Appropriate use criteria for lymphoscintigraphy in sentinel node mapping and lymphedema/lipedema

by Society of Nuclear Medicine and Molecular ImagingCredit: Pixabay/CC0 Public DomainThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) and 10 other professional societies have issued new a
World medicine December 12,2023
Appropriate use criteria for lymphoscintigraphy in sentinel node mapping and lymphedema/lipedema

Appropriate use criteria for lymphoscintigraphy in sentinel node mapping and lymphedema/lipedema

by Society of Nuclear Medicine and Molecular ImagingCredit: Pixabay/CC0 Public DomainThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) and 10 other professional societies have issued new a
World medicine December 12,2023
Clinical trial confirms immunotherapy drug's efficiency for treating lung cancer

Clinical trial confirms immunotherapy drug's efficiency for treating lung cancer

byMcGill University Health CentreCredit: Pixabay/CC0 Public DomainTogether, the McGill University Health Centre (MUHC), the Centre hospitalier de l'Université de Montréal (CHUM) and St. Mary
World medicine December 12,2023
Clinical trial confirms immunotherapy drug's efficiency for treating lung cancer

Clinical trial confirms immunotherapy drug's efficiency for treating lung cancer

byMcGill University Health CentreCredit: Pixabay/CC0 Public DomainTogether, the McGill University Health Centre (MUHC), the Centre hospitalier de l'Université de Montréal (CHUM) and St. Mary
World medicine December 12,2023
Clinical trial: Adding ribociclib to hormone therapy improves outcomes in patients with early breast cancer

Clinical trial: Adding ribociclib to hormone therapy improves outcomes in patients with early breast cancer

byUniversity of California, Los AngelesCredit: Unsplash/CC0 Public DomainA study involving UCLA Jonsson Comprehensive Cancer Center researchers found when ribociclib, a targeted therapy drug, is
World medicine December 12,2023
Clinical trial: Adding ribociclib to hormone therapy improves outcomes in patients with early breast cancer

Clinical trial: Adding ribociclib to hormone therapy improves outcomes in patients with early breast cancer

byUniversity of California, Los AngelesCredit: Unsplash/CC0 Public DomainA study involving UCLA Jonsson Comprehensive Cancer Center researchers found when ribociclib, a targeted therapy drug, is
World medicine December 12,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com